TY  - JOUR
AU  - Herrera-Hidalgo, Laura
AU  - Luque-Marquez, Rafael
AU  - de Alarcon, Aristides
AU  - Guisado-Gil, Ana Belen
AU  - Gutierrez-Gutierrez, Belen
AU  - Navarro-Amuedo, Maria Dolores
AU  - Praena-Segovia, Julia
AU  - Carmona-Caballero, Juan Manuel
AU  - Fraile-Ramos, Elena
AU  - Gutierrez-Valencia, Alicia
AU  - Lopez-Cortes, Luis Eduardo
AU  - Gil-Navarro, Maria Victoria
PY  - 2022
DO  - 10.3390/jcm11061551
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/21255
T2  - Journal of clinical medicine
AB  - Cefazolin is a recommended treatment for methicillin-susceptible Staphylococcus aureus (MSSA) infections that has been successfully used in outpatient parenteral antibiotic therapy (OPAT) programs. The aim of this study was to assess the clinical...
LA  - en
PB  - MDPI AG
KW  - MSSA
KW  - OPAT
KW  - cefazolin
KW  - home-delivery
KW  - methicillin-susceptible Staphylococcus aureus
KW  - Anti-Bacterial Agents
KW  - Methicillin
KW  - Staphylococcus aureus
KW  - Outpatients
KW  - Anti-Infective Agents
KW  - Treatment Failure
KW  - Retrospective Studies
TI  - Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.
TY  - research article
VL  - 11
ER  -